WHAT WE DO
CLINICAL TRIALS AND STUDIES
AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!
Phergain Collaborators’ Ecosystem in Spain.
Advancing Oncology Care: MEDSIR at ASCO Annual Meeting
MEDSIR at ASCO 2023
Revolutionizing Patient Care: MEDSIR's Hope for HER2-Positive Early Breast Cancer
Promising Advancements in Oncology Research Unveiled at ASCO Annual Meeting
Strategic partnership between MEDSIR and REVEAL GENOMICS® for cancer research
Spotlight - LINGain biomarker study
We enjoyed presenting our work at ESMO BREAST 2022
We’re presenting at ESMO Breast Cancer 2022!
WHAT A 2021 WE HAD!
Spotlight: PHERGain-2 HER2+ early breast cancer trial
Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer
Chemotherapy de-escalation: outstanding advances in the treatment of breast cancer
PHERGain Study (breast)